Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems

Journal of Pharmacology and Experimental Therapeutics

Volumn 299, Issue 1, 2001, Pages 332-342

  Fedorova, Irina ^a   Hashimoto, Akihiro ^a   Fecik, Robert A ^b   Hedrick, Michael P ^b   Hanuš, Lumír O ^a   Boger, Dale L ^b   Rice, Kenner C ^a   Basile, Anthony S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 CHLOROPHENYL) 1 (1H INDOL 3 YLMETHYL)PIPERIDIN 4 OL; 4 AMINOBUTYRIC ACID A RECEPTOR; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ANXIOLYTIC AGENT; BICUCULLINE; CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; CAPSAZEPINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ENZYME INHIBITOR; FATTY ACID AMIDASE; FATTY ACID DERIVATIVE; HYPNOTIC AGENT; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; OLEAMIDE; RIMONABANT; SEROTONIN 1A ANTAGONIST; SEROTONIN 2C ANTAGONIST; UNCLASSIFIED DRUG; WIN 52466;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; GABAERGIC SYSTEM; MALE; MAZE TEST; MOTOR PERFORMANCE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; TAIL FLICK TEST; TRANQUILIZING ACTIVITY;

AMIDOHYDROLASES; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CATALEPSY; DRUG TOLERANCE; ENZYME INHIBITORS; MALE; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; OLEIC ACIDS; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SOCIAL BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0034807833     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Anandamide, an endogenous cannabinoid, has a very low physical dependence potential
2. Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: A comparison between the effects produced by pre- and postsynaptic inhibition of dopaminergic neurotransmission
3. Characterization of the hypnotic actions of oleamide
4. Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide
5. Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: Potential for interaction with brain cannabinoid receptors
6. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum
7. The effects of anandamide on memory consolidation in mice involve both D1 and D2 dopamine receptors
8. Behavioral effects of cannabinoid agents in animals
9. 9-tetrahydrocannabinol
10. Hydrolysis studies on oleamide in simulated gastrointestinal fluids
11. Precipitated and spontaneous withdrawal in rats tolerant to anandamide
12. Molecular characterization of an enzyme that degrades neuromodulatory fatty acid amides
13. Chemical characterization of a family of brain lipids that induce sleep
14. A method for determining loss of pain sensation
15. Effects of cannabinoids on prolactin and gonadotrophin secretion: Involvement of changes in hypothalamic gamma-aminobutyric acid inputs
16. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
17. Synthetic analgesics. II. Dithienyl-butenyl- and dithienylbutylamines
18. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM374)
19. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
20. The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells
21. 1 receptor
22. A gas chromatographic-mass spectral assay for the quantitative determination of oleamide in biological fluids
23. Some narcotic antagonists in the benzomorphan series
24. Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors
25. Locomotor activity and exploration
26. The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:Protein N-myristoyltransferase
27. Pharmacological and biochemical interactions between opioids and cannabinoids
28. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene
29. Anandamide may mediate sleep induction
30. The hypnotic actions of oleamide are blocked by a cannabinoid antagonist
31. Erucamide
32. 9-tetrahydrocannabinol in rats
33. Inhibition of oleamide hydrolase catalyzed hydrolysis of the endogenous sleep-inducing lipid. cis-9-octadecenamide
34. Stress and emotionality: A multidimensional and genetic approach
35. The elevated plus-maze: Pharmacology, methodology and ethology
36. Enzymatic synthesis of oleamide (cis-9, 10-octadecenoamide), an endogenous sleep-inducing lipid, by rat brain microsomes
37. Anandamide an endogenous activator of the vanilloid receptor
38. Unique allosteric regulation of 5-hydroxytryptamine receptor mediated signal transduction by oleamide
39. Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system
40. Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration